SUBSCRIBERS

Medtech investor Clearbridge Health plans Catalist IPO

It expects operating expenses to go up in the near term after IPO, and can't be certain that it will achieve profitability

Published Mon, Nov 27, 2017 · 09:50 PM

IPO

Singapore

CLEARBRIDGE Health, the medtech investor formerly known as Clearbridge Accelerator, is planning an initial public offering (IPO) on the Singapore Exchange.

Clearbridge Health, which was renamed in April, lodged a draft prospectus for a listing on the Catalist board last Friday.

Founded by non-executive non-independent chairman Johnson Chen in 2010, Clearbridge Health describes itself as a healthcare company with a focus on precision medicine in Asia, including laboratory testing, diagnostics and personalis…

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes